Abstract
This paper reviews the existing epidemiological and clinical evidence about the relationships of non-diabetic microalbuminuria with cardiovascular risk factors such as elevated blood pressure (BP), systolic particularly, cardiac hypertrophy, adverse metabolic status, smoking habits, elevated angiotensin II levels, endothelial dysfunction, acute and perhaps subclinical inflammation. Because of that unique property of reflecting the influence of so many clinically relevant parameters, microalbuminuria may legitimately be defined as an integrated marker of cardiovascular risk, an unique profile among the several prognostic predictors available to stratify risk in hypertensive patients. Recent cohort studies also showed associations with cardiovascular morbidity and mortality independently from conventional atherogenic factors. This behaviour, whose understanding still needs further elucidation, suggests to measure albuminuria and to screen patients at a higher absolute risk in whom preventive treatment is expected to be more beneficial than in those with a lower absolute risk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parving HH, Jensen HA, Mogensen HA, Evrin PE . Increased urinary albumin excretion rate in benign essential hypertension Lancet 1974 i: 1190–1193
Yudkin JS, Forrest RD, Jackson C . Microalbuminuria as predictor of vascular disease in non diabetic subjects Lancet 1988 2: 530–533
Pedrinelli R . Microalbuminuria in hypertension Nephron 1996 73: 499–505
Pedrinelli R, Dell'Omo G, Penno G, Mariani M . Non diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease Vasc Med 2001 in press
Gerstein HC et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 2001 25: 421–426
Roest M et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women Circulation 2001 103: 3057–3061
Gerber LM, Johnston K, Alderman MH . Assessment of a new dipstick test in screening for microalbuminuria inpatients with hypertension Am J Hypertens 1998 11: 1321–1327
Mogensen CE et al. Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria Diabetes Care 1997 20: 1642–1646
Bog-Hansen E et al. Impaired glucose metabolism and obesity in Swedishpatients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project Diabetes Obes Metab 2001 3: 25–31
Haffner SM et al. Is microalbuminuria part of theprediabetic state? The Mexico City Diabetes Study Diabetologia 1993 36: 1002–1006
Agrawal B, Berger A, Wolf K, Luft FC . Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension J Hypertens 1996 14: 223–228
Gatzka CD et al. Left ventricular mass and microalbuminuria: relation to ambulatory blood pressure. Hypertension Diagnostic Service Investigators Clin Exp Pharmacol Physiol 1999 26: 514–516
Jiang X et al. Microalbuminuria in young adults related to blood pressure in a biracial (black-white) population. The Bogalusa Heart Study Am J Hypertens 1994 7: 794–800
Gerstein HC et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabeticpatients in the Heart Outcomes Prevention Evaluation Study Diabetes Care 2000 23 (Suppl 2): B35–B39
Mangili R et al the Italian Microalbuminuria Study Group. Prevalence of hypertension and microalbuminuria in adult type 1 (insulin dependent)diabeticpatients without renal failure in Italy: Validation of screening techniques to detect albuminuria Acta Diabetol 1992 29: 156–166
Jensen JS et al. Detecting microalbuminuria by urinary albumin/creatinine concentration ratio Nephrol Dial Transplant 1997 12 (Suppl 2): 6–9
Gosling P, Beevers DG . Urinary albumin excretion and blood pressure in the general population Clin Sci 1989 76: 39–42
Cirillo M et al. Microalbuminuria in non diabetic adults. Relation of blood pressure, body mass index, plasma cholesterol levels and smoking: the Gubbio population study Arch Int Med 1998 158: 1933–1939
Gould MM et al. Microalbuminuria: associations with height and sex in non diabetic subjects BMJ 1993 306: 240–242
Kuusisto J, Mykkanen L, Pyorala K, Laakso M . Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease Circulation 1995 91: 831–837
Mikkänen L et al. Microalbuminuria precedes the development of NIDDM Diabetes 1994 43: 552–557
Jager A et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and allcause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study Arterioscler Thromb Vasc Biol 1999 19: 617–624
Jensen JS et al. Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals J Hum Hypertens 1997 11: 727–732
Palatini P et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study Hypertension 1998 31: 57–63
Pontremoli R et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications Hypertension 1997 30: 1135–1143
Hörner D, Fliser DD, Klimm HP, Ritz E . Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners J Hypertens 1996 14: 655–660
Pierdomenico SD et al. Target organ status and serum lipids inpatients with white coat hypertension Hypertension 1995 26: 801–807
Hoegholm A, Kristensen KS, Bang LE, Nielsen JW . White coat hypertension and target organ involvement: the impact of different cut-off levels on albuminuria and left ventricular mass and geometry J Hum Hypertens 1998 12: 433–439
Williams SA et al. Capillary hypertension and abnormal pressure dynamics inpatients with essential hypertension Clin Sci 1990 79: 5–8
Hoegholm A et al. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension Hypertension 1994 24: 101–105
Gilbert RE, Phillips P, Jerums G . Relationship between ambulatory blood pressure and albuminuria in normal subjects Am J Hypertens 1991 4: 959–962
Clausen P et al. Ambulatory blood pressure and urinary albumin excretion in clinically healthy subjects Hypertension 1998 32: 71–77
Nielsen S, Dollerup J, Nielsen B, Mogensen CE . Combination of enalapril and low-dose thiazide reduces normoalbuminuria in essential hypertension J Hypertens 1998 16: 1539–1544
Christensen CK . Rapidly reversible albumin and beta2-microglobulin hyperexcretion in recent severe essential hypertension J Hypertens 1983 1: 45–51
Biesenbach G, Zazgornik J . High prevalence of hypertensive retinopathy and coronary artery disease in hypertensivepatients with persistent microalbuminuria under short intensive antihyperetensive therapy Clin Nephrol 1994 41: 211–218
Pedersen EB, Mogensen CE . Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow inpatients with essential hypertension Scand J Clin Lab Invest 1976 36: 231–237
Yamada T, Ishihara M, Ichikawa K, Hiramatsu K . Proteinuria and renal function during antihypertensive treatment for essential hypertension J Am Ger Ass 1980 28: 114–117
Persson B et al. Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria J Int Med 1992 251: 48–52
Erley CM et al. Microalbuminuria in essential hypertension. Reduction by antihypertensive drugs Hypertension 1993 21: 810–815
Abraham PA et al. Urinary albumin and N-Acetyl-β-D-Glucosaminidase excretions in mild hypertension Am J Hypertens 1994 7: 965–974
Laviades C, Varo N, Diez J . Transforming growth factor β in hypertensives with cardiorenal damage Hypertension 2000 36: 517–522
Bigazzi R et al. Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion inpatients with essential hypertension Am J Hypertens 1993 6: 108–113
Ogawa Y et al. Effects of lisinopril and nitrendipine on urinary albumin excretion and renal function inpatients with mild to moderate essential hypertension Hypertens Res 2000 23: 607–612
Pontremoli R et al. Long term effect of Nifedipine GITS and Lisinopril on subclinical organ damage inpatients with essential hypertension J Nephrol 2001 14: 19–26
Pedrinelli R et al. Forearm reserve and the cardiac and renal indices of pressure load in normo- and hypertensives Hypertension 1994 24: 24–29
Folkow B . The ‘structural factor’ in hypertension: with special emphasis on the hypertrophic adaption of the systemic resistance vessels. In: Laragh JH, Brenner BM (eds) Hypertension: Pathophysiology, Diagnosis and Management Raven Press: New York 1990 chap 37 pp 547–564
Clausen P et al. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects Circulation 2001 103: 1869–1874
Cirillo M et al. Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group Kidney Int 2000 58: 1211–1218
Pedrinelli R et al. Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men Hypertension 2000 35: 48–54
Tsioufis CP et al. Microalbuminuria is associated with abnormal thoracic aortic mechanics in essential hypertension Am J Cardiol 2000 86: 797–801
Pinto-Sietsma S-J et al. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population J Am Soc Nephrol 2000 11: 1882–1888
Agewall S, Fagerberg B . Risk factors that predict development of microalbuminuria in treated hypertensive men. The Risk Intervention Study Group Angiology 1996 47: 963–972
Goetz FC et al. Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study Am J Epidemiol 1997 145: 91–102
Verdecchia P . Prognostic value of ambulatory blood pressure: current evidence and clinical implications Hypertension 2000 35: 844–851
Smulyan H, Safar ME . Systolic blood pressure revisited J Am Coll Cardiol 1997 29: 1407–1413
Jensen JS . Microalbuminuria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations Med Bull 2000 47: 63–78
Pedrinelli R et al. Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men Hypertension 1998 32: 312–318
Pedrinelli R et al. Microalbuminuria and transvascular albumin leakage in essential hypertension Hypertension 1999 34: 491–495
Pedrinelli R et al. Dissociation between microalbuminuria and common carotid thickness in essential hypertensive men J Hum Hypertens 2000 14: 831–835
Borch-Johnsen K et al. Urinary albumin excretion. An independent predictor of ischemic heart disease Arterioscler Thromb Vasc Biol 1999 19: 1992–1997
Jensen JS et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease Hypertension 2000 35: 898–903
Poulsen PL, Ebbehoj E, Hansen KW, Mogensen CE . High normo- or low microalbuminuria: basis for intervention in insulin-dependent diabetes mellitus Kidney Int 1997 63: S15–S18
Nishijo M et al. Microalbuminuria and hypertension in nondiabetic Japanese men Am J Hypertens 1999 12: 16–20
Tomura S et al. Prevalence of microalbuminuria and relationship to the risk of cardiovascular disease in the Japanese population Am J Nephrol 1999 19: 13–20
Kim CH et al. Association of microalbuminuria and atherosclerotic risk factors in non-diabetic subjects in Korea Diabetes Res Clin Pract 1998 40: 191–199
Bianchi S et al. Elevated serum insulin levels inpatients with essential hypertension and microalbuminuria Hypertension 1994 23: 681–687
Bianchi S et al. Insulin resistance in microalbuminuric hypertension. Sites and mechanisms Hypertension 1995 26: 789–795
Agewall S et al. Microalbuminuria, insulin sensitivity and hemostatic factors in non diabetic treated hypertensive men J Int Med 1995 237: 195–203
Redon J et al. Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension J Hypertens 1997 15: 79–86
Andronico G et al. Insulin, sodium-lithium countertransport, and microalbuminuria in hypertensivepatients Hypertension 1998 31: 110–113
Collins VR et al. Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru Diabetes 1989 38: 1602–1610
Haffner SM et al. Microalbuminuria Potential marker for increased cardiovascular risk factors in non diabetic subjects, Arteriosclerosis 1990 10: 727–731
Reaven GM . Insulin resistance and human disease: a short history J Basic Clin Physiol Pharmacol 1998 9: 387–406
Tomiyama H et al. The relationship of hyperinsulinemic state to left ventricular hypertrophy, microalbuminuria, and physical fitness in borderline and mild hypertension Am J Hypertens 1997 10: 587–591
Mykkanen L et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study Diabetes 1998 47: 793–800
Calviño J et al. Atherosclerosis profile and microalbuminuria in essential hypertension Am J Kidney Dis 1999 34: 996–1001
Metcalf P et al. Albuminuria in people at least 40 year old: effect of obesity, hypertension and hyperlipidemia Clin Chem 1992 38: 1802–1808
Løkkegaard N, Haupter I, Kristensen TB . Microalbuminuria in obesity Scand J Urol Nephrol 1992 26: 275–278
Bigazzi R, Bianchi S, Baldari G, Campese VM . Clustering of cardiovascular risk factors in salt-sensitivepatients with essential hypertension: role of insulin Am J Hypertens 1996 9: 24–32
Hilsted J, Christensen NJ . Dual effect of insulin on plasma volume and transcapillary albumin transport Diabetologia 1992 35: 99–103
Catalano C et al. Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects Diabetes 1997 46: 868–875
Yudkin JS . Microalbuminuria: a genetic link between diabetes and cardiovascular disease? Ann Med 1992 24: 517–522
Forsblom CM et al. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives ofpatients with NIDDM Diabetologia 1995 38: 363–369
Nosadini R et al. Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension Hypertension 1991 18: 191–198
Falkner B, Kushner H, Levison S, Canessa M . Albuminuria in association with insulin and sodium-lithium countertransport in young African Americans with borderline hypertension Hypertension 1995 25: 1315–1321
Mahnensmith RL, Aronson PS . The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes Circ Res 1985 56: 773–778
Giampietro O et al. Microalbuminuria and erythrocyte sodium-hydrogen exchange in essential hypertension Hypertension 1995 25: 981–985
Winocour PH et al. Microalbuminuria and associated cardiovascular risk factors in the community Atherosclerosis 1992 93: 71–81
Zavaroni I et al. Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population J Int Med 1996 240: 151–156
Jager A et al. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study Diabetologia 1998 41: 694–700
Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B . Insulin sensitivity in clinically healthy individuals with microalbuminuria Atherosclerosis 1996 119: 69–76
Hodge AM, Dowse GK, Zimmet PZ . Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus Diabet Med 1996 13: 441–449
Woo J et al. Microalbuminuria and other cardiovascular risk factors in non diabetic subjects Int J Cardiol 1992 37: 345–350
Foyle WJ, Carstensen E, Fernandez MC, Yudkin JS . Longitudinal study of associations of microalbuminuria with the insulin resistance syndrome and sodium lithium countertransport in non diabetic subjects Arterioscler Thromb Vasc Biol 1995 15: 1330–1337
Robbins DC et al. Regional differences in albuminuria among American Indians: an epidemic of renal disease Kidney Int 1996 49: 557–563
Ribstein J, du Cailar G, Mimran A . Combined renal effects of overweight and hypertension Hypertension 1995 26: 610–615
Yip JW et al. Insulin resistance inpatients with essential hypertension can occur in absence of microalbuminuria Am J Hypertens 1996 9: 959–963
Pedrinelli R et al. Dissociation between albuminuria and insulinemia in hypertensive and atherosclerotic men J Hum Hypertens 1999 13: 129–134
Grandi AM et al. Microalbuminuria in never-treated hypertensives: lack of relationship to hyperinsulinemia and genetic predisposition to hypertension Am J Hypertens 2000 13: 353–358
Alderman MH et al. Plasma renin activity: a risk factor for myocardial infarction in hypertensivepatients Am J Hypertens 1997 10: 1–8
Baldoncini R et al. High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertension Kidney Int 1999 56: 1499–1504
Pontremoli R et al. The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension J Am Soc Nephrol 1996 7: 2550–2558
Kario K et al. Hypertensive nephropathy and the gene for angiotensin-converting enzyme Arterio-scler Thromb Vasc Biol 1997 17: 252–256
Agerholm-Larsen B, Tybjserg-Hansen A, Schnohr P, Nordestgaard BG . ACE gene polymorphism explains 30–40% of variability in serum ACE activity in both women and men in the population at large: the Copenhagen City Heart Study Atherosclerosis 1999 147: 425–427
Pontremoli R et al. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension Kidney Int 2000 57: 561–569
Chase PH et al. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes JAMA 1991 265: 614–617
Corradi L et al. Association between smoking and microalbuminuria in hypertensivepatients with type 2 diabetes mellitus J Hypertens 1993 11 (Suppl 5): s190–s191
Gosling P, Shearman CP, Beevers DG . Urinary albumin excretion in smokers and non smokers Contrib Nephrol 1990 83: 151–155
Metcalf PA et al. Albuminuria in people at least 40 years old: effect of alcohol consumption, regular exercise, and cigarette smoking Clin Chem 1993 39: 1793–1797
Mimran A, Ribstein J, Du Cailar G, Halimi JM . Albuminuria in normals and essential hypertension J Diab Comp 1994 8: 150–156
Pedrinelli R et al. Microalbuminuria and endothelial dysfunction in essential hypertension Lancet 1994 344: 14–18
Spangler JG, Bell RA, Summerson JH, Konen JC . Correlates of abnormal urinary albumin excretion rates among primary carepatients with essential hypertension J Am Board Fam Pract 1997 10: 180–184
Pinto-Sietsma S-J et al. Smoking is related to albuminuria and abnormal renal function in non diabetic persons Ann Intern Med 2000 133: 585–591
Michael Pittilo R . Cigarette smoking, endothelial injury and cardiovascular disease Int J Exp Pathol 2000 81: 219–230
Redon J et al. Microalbuminuria is correlated with left ventricular hypertrophy in male hypertensivepatients J Hypertens 1991 9: S148–S149
Berrut G et al. Microalbuminurie et hypertrophie ventriculaire gauche au cours de l'hypertension arterielle essentielle La Presse Medicale 1992 21: 1275–1278
Cerasola G et al. Microalbuminuria points out early renal and cardiovascular changes in essential hypertension Rev Lat Cardiol 1992 13: 3–7
Pedrinelli R et al. Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atheroscleroticpatients Arteriosclerosis 1993 13: 900–906
Cerasola G et al. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension J Hypertens 1996 14: 915–920
Wu SG, Jung FR, Wei SY, Su CZ . Relationship between microalbuminuria, left ventricular mass and function in essential hypertension Kaohsiung J Med Sci 1998 14: 536–541
Pontremoli R et al. Microalbuminuria is an early marker of target organ damage in essential hypertension Am J Hypertens 1998 11: 430–438
Nilsson T et al. The relations of microalbuminuria to ambulatory blood pressure and myocardial wall thickness in a population J Intern Med 1998 244: 55–59
Pontremoli R et al. Left ventricular geometry and function inpatients with essential hypertension and microalbuminuria J Hypertens 1999 17: 993–1000
Koren MJ et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension Ann Intern Med 1991 114: 345–355
Mc Murray J et al. The effect of atrial natriuretic factor on urinary albumin and beta 2-microglobulin excretion in man J Hypertens 1988 6: 783–786
Nishikimi T et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension Hypertension 1996 28: 22–30
Vakili BA, Okin PM, Devereux RB . Prognostic implications of left ventricular hypertrophy Am Heart J 2001 141: 334–341
Viberti GC et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus Lancet 1982 1: 1430–1432
Mimran A, Ribstein J, DuCailar G . Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertension 1994 23: 1018–1021
Reid M, Bennett F, Wilks R, Forrester T . Microalbuminuria, renal function and waist:hip ratio in black hypertensive Jamaicans J Hum Hypertens 1998 12: 221–227
Mattei P et al. Microalbuminuria and renal hemodynamics in essential hypertension Eur J Clin Invest 1997 27: 755–760
Pontremoli R et al. Increased renal resistive index inpatients with essential hypertension: a marker of target organ damage Nephrol Dial Transplant 1999 14: 360–365
Losito A, Fortunati F, Zampi I, Del Favero A . Impaired renal functional reserve and albuminuria in essential hypertension Br Med J 1988 296: 1562–1564
Whelton PK, Perneger TV, He J, Klag MJ . The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence J Hum Hypertens 1996 10: 683–689
Halimi JM et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population Kidney Int 2000 58: 1285–1292
Schmieder RE et al. Predictors for hypertensive nephropathy: results of a 6-year follow-up study in essential hypertension J Hypertens 1995 13: 357–365
Bigazzi R, Bianchi S, Baldari D, Campese VM . Microalbuminuria predicts cardiovascular events and renal insufficiency inpatients with essential hypertension J Hypertens 1998 16: 1325–1333
Susic D, Frohlich ED . Nephroprotective effect of antihypertensive drugs in essential hypertension J Hypertens 1998 16: 555–567
Lydakis C, Efstratopoulos A, Lip GY . Microalbuminuria in hypertension: is it up to measure? J Hum Hypertens 1997 11: 695–697
Dimmitt SB et al. Urine albumin excretion in healthy subjects J Hum Hypertens 1993 7: 239–243
Gorgels WJ et al. Urinary excretions of high molecular weight beta-thromboglobulin and albumin are independently associated with coronary heart disease in women, a nested case-control study of middle-aged women in the Diagnostisch Onderzoek Mammacarcinoom (DOM) Cohort, Utrecht, Netherlands Am J Epidemiol 1995 142: 1157–1164
Beatty OL et al. Microalbuminuria does not predict cardiovascular disease in a normal general practice population Ir J Med Sci 1993 162: 140–142
Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen G The Copenhagen City Heart Study Group. Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects Scand J Clin Lab Invest 1993 53: 867–872
Guest CS, Ratnaike S, Larkins RG . Albuminuria in aborigines and Europids of south-eastern Australia Med J Aust 1993 159: 335–338
Tichet J et al. Epidemiology of microalbuminuria in a French population J Diabetes Complications 1994 8: 174–175
Hoogeveen EK et al. Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study Kidney Int 1998 54: 203–209
Mennen LI et al. Microalbuminuria and markers of the atherosclerotic process: the D.E.S.I.R. study Atherosclerosis 2001 154: 163–169
Diercks GF et al. Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of Renal and vascular Endstage disease) study Eur Heart J 2000 21: 1922–1927
Hwang KK et al. Microalbuminuria in urban Zimbabwean women J Hum Hypertens 2000 14: 587–593
Mykkanen L et al. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The insulin resistance atherosclerosis study (IRAS) Stroke 1997 28: 1710–1716
Summerson JH, Bell RA, Konen JC . Racial differences in the prevalence of microalbuminuria in hypertension Am J Kidney Dis 1995 26: 577–579
Redon J et al. Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability J Hypertens 1994 12: 947–953
Agewall S et al. Microalbuminuria in treated men at high risk of coronary disease J Hypertens 1993 11: 461–469
Nelson RG et al. Albuminuria in type 2 (non insulin dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians Diabetologia 1989 32: 870–876
Metcalf PA et al. Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity Diabetes Care 1993 16: 1485–1493
Agabiti-Rosei E et al. Arterial hypertension and heart diseases. Diagnostic-therapeutic guidelines. Joint Commission of the National Association of Hospital Cardiologists, the Italian Society of Cardiology and the Italian Society of Arterial Hypertension Cardiologia 1999 44: 299–312
Lewis EJ et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan inpatients with nephropathy due to type 2 diabetes N Engl J Med 2001 345: 851–860
Agodoa LY et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial JAMA 2001 285: 2719–2728
Tarazi RC . Regression of left ventricular hypertrophy by medical treatment: present status and possible implications Am J Med 1983 75: 80–86
Schillaci G et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension Circulation 1998 97: 48–54
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pedrinelli, R., Dell'Omo, G., Di Bello, V. et al. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 16, 79–89 (2002). https://doi.org/10.1038/sj.jhh.1001316
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001316
Keywords
This article is cited by
-
Association of 24-h urinary sodium excretion with microalbuminuria in a Chinese population
Scientific Reports (2023)
-
Comparing the associations of clinic vs. ambulatory blood pressure with subclinical organ damage in young healthy adults: the African-PREDICT study
Hypertension Research (2021)
-
Vascular, cardiac and renal target organ damage associated to arterial hypertension: which noninvasive tools for detection?
Journal of Human Hypertension (2020)
-
Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients
Journal of Human Hypertension (2016)
-
Microalbuminuria in primary hypertension: a guide to optimal patient management?
Journal of Nephrology (2016)